礼来Eli Lilly & Co. (LLY) 2014年年度报告「NYSE」.pdf

1、It begins with a promise Monica Kumado Lilly Global ManufacturingELI LILLY AND COMPANY 2014 ANNUAL REPORT NOTICE OF 2015 ANNUAL MEETING PROXY STATEMENTIt begins with a promiseIn 1876,Colonel Eli Lilly founded the company that bears his name to make trusted medicines of the highest possible quality,b

2、ased on the best science of the day.In 2014,the people of Eli Lilly and Company launched three new medicines to treat diabetes and cancer and gained approval for a fourthmedicines that represent the ongoing fulfillment of the promise made more than 138 years ago by our founder.These new medicines,an

3、d more to come,are the fruit of the commitment we made late in the last decade,to sustain our investment in innovation as we entered a challenging period of patent expirations on many of our key products.These medicines also reflect Colonel Lillys promise of quality,brought to life every day by thou

4、sands of Lilly people in our manufacturing and quality organizations.Today,Eli Lilly and Company continues to pursue the promise of innovationguided by our core values of integrity,excellence,and respect for peopleas we prepare to launch more new medicines to bring healing and hope to people around

5、the world.On the cover:Monica Kumado works on a packaging line for Humalog vials in Lillys manufacturing operations in Indianapolis.Generations of Lilly manufacturing employees have sustained Lillys commitment to producing quality medicines.YEAR IN REVIEW 1 Financial Highlights 2 Letter to Sharehold

6、ers 6 It begins with a promise 12 Pipeline of Molecules in Clinical DevelopmentFINANCIALS 2 Business 15 Risk Factors 21 Managements Discussion and Analysis of Results of Operations and Financial Condition 41 Consolidated Statements of Operations 42 Consolidated Statements of Comprehensive Income 43